For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT04095364
NRG-GY019: A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Contact Name:
Steven Schmitt
Study Type:
Oncology - Gynecologic
Study Status:
Open to Accrual
Principal investigator:
Kimberly Levinson, MD
IRB number :
1524088
Study Number:
GY019
Phone:
Fax:
NRG-GY026: A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) or pertuzumab trastuzumab and hyaluronidase-zzfx (PHESGO) in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma
Contact Name:
Study Type:
Oncology - Gynecologic
Study Status:
Open to Accrual
Principal investigator:
Kimberly Levinson, MD
IRB number :
1997970
Study Number:
NRG-GY026
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05256225
Randomized, multicenter, open-label, Phase 3 study of mirvetuximab soravtansine in combination with bevacizumab versus bevacizumab alone as maintenance therapy for patients with FR alpha; high recurrent platinum-sensitive epithelial ovarian, fallopian tube, or primary peritoneal cancers who have not progressed after second line platinum-based chemotherapy plus bevacizumab (GLORIOSA)
Contact Name:
Study Type:
Oncology - Gynecologic
Study Status:
Open to Accrual
Principal investigator:
Fong Liu, MD
IRB number :
2037615
Study Number:
GOG3078 (G2303)
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05445778
RTOG R1216: Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Contact Name:
Steven Schmitt
Study Type:
Oncology - Head and Neck
Study Status:
Open to Accrual
Principal investigator:
Mei Tang, MD
IRB number :
483559
Study Number:
RTOG R1216
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT01810913
S1803: Lenalidomide +/​- Daratumumab/​rHuPh20 as Post-ASCT Maintenance for MM w/​MRD to Direct Therapy Duration (DRAMMATIC)
Contact Name:
Study Type:
Oncology - Leukemia/Lymphoma/Myeloma
Study Status:
Open to Accrual
Principal investigator:
Zhuoyan, Li, MD
IRB number :
2184196
Study Number:
S1803
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT04071457